ADIoS

The latest version is compliant with CQC requirements and NICE guidance.
In June 2018, the CQC said: “Nationally there is a general naivety about diversion issues.” Its update on the safer management of controlled drugs, published in July 2018, added: “Health and care staff should consider regular monitoring and auditing arrangements for controlled drugs in the lower schedules to identify and take swift action on diversion,” and “governance and reporting of concerns around controlled drugs should be included as part of commissioning and contracting arrangements.”
ADIoS has a proven track record of enhancing security and accountability of drug usage in trusts across the country. It runs on the trusted Define platform.
The software monitors around 1,200 drug formulations for a hospital, with a simplified visual display that tracks back to ward-level. Viewing the data over a period of time enables the hospital to ensure the safety and accountability of abusable drugs.